Reversed Phase Chromatography

Hydrophobic LC for analytical separations of peptides and compatible analytes.

Reversed-phase chromatography, panels A–D. A: Analytes interact with bonded nonpolar ligands in an aqueous-rich mobile phase. B: Increasing organic modifier releases a less-retained blue analyte. C: A more-retained orange analyte elutes at higher organic content. D: The organic-modifier trend increases during elution. The ordering is illustrative and depends on analyte, stationary phase, and conditions; protein structure and activity are not guaranteed to survive.
Reversed-phase chromatography: four-panel overview. A: Analytes interact with bonded nonpolar ligands in an aqueous-rich mobile phase. B: Increasing organic modifier releases a less-retained blue analyte. C: A more-retained orange analyte elutes at higher organic content. D: The organic-modifier trend increases during elution. The ordering is illustrative and depends on analyte, stationary phase, and conditions; protein structure and activity are not guaranteed to survive. Schematics and traces are conceptual, not measured data; a.u. means arbitrary units. Dashed gradient lines, where shown, indicate direction only. Open full-size figure.

Principle

RPC resins present nonpolar alkyl chains (C4, C8, C18). Analytes bind by hydrophobic interaction in aqueous buffer and are eluted by increasing organic modifier concentration. Retention and recovery depend on stationary phase, pore structure, temperature, mobile phase, and analyte. C4, C8, and C18 are common choices, but no chain length is universally best for intact proteins or peptides.

Reversed phase stationary phase and gradient elution orderLeft: butyl, octyl and octadecyl chains bonded to a silica surface, with an analyte moving between the mobile phase and the chains. Right: a chromatogram in which three peaks elute during a rising organic modifier gradient, the least hydrophobic first and the most hydrophobic last.A Bonded phasesilica particle surface (Si–O–Si)SiC4SiC8SiC18chain length shown schematically; no length is universally bestanalytemobile phase(water + organic modifier)adsorbed on chainsB Gradient elution05101520050100Elution volume (column volumes, illustrative)UV absorbance (a.u.)Organic modifier, %Blesshydrophobicmorehydrophobic
Reversed phase chromatography, schematic. A: n-alkyl chains (C4, C8, C18) bonded to silica form the hydrophobic stationary phase; analytes exchange continuously between the aqueous mobile phase and the chains. B: as the organic-modifier fraction (%B) rises, analytes elute in order of increasing hydrophobicity. Axes are illustrative, not a method. Organic solvent and the hydrophobic surface can unfold proteins and reduce recovery of activity, so check structure and activity when they matter. Principle, elution order and denaturation risk: Cytiva™, Hydrophobic interaction and reversed phase chromatography: principles and methods (handbook, read 2026-09-25).

Method development

Organic modifier, acid, temperature, gradient, and stationary phase must be selected and validated for the analyte and detector. Use the column and instrument manuals to set solvent compatibility and pressure limits; this page does not prescribe a universal mobile phase or gradient.

Applications

  • Peptide mapping: RP separation can precede a suitably validated identification workflow; retention alone does not establish sequence or modification identity.
  • Small molecules and peptides: RP can provide useful analytical or preparative separation when recovery and compatibility are demonstrated.
  • Intact proteins or ADCs: use a fit-for-purpose, validated method and an appropriate detector/orthogonal assay for mass, truncation, or DAR questions. Chromatography alone does not confirm mass, sequence, or DAR.

Notes on protein RPC

RP conditions can denature proteins and reduce recovery, but the effect is analyte- and method-dependent. Establish structural integrity, activity, and recovery experimentally whenever they matter. HIC may be a useful alternative in some workflows, not a universal substitute; RP can be analytical or preparative for compatible analytes.

Sources and scope

Biopharmaceutical Analysis by HPLC: Practices and Challenges (secondary review; accessed 2026-09-25) supports RP-HPLC’s analytical uses and condition-dependent denaturation/recovery risks. The source does not justify universal C4/C18, solvent, or DAR prescriptions.

Try it on a trace

Open a two-column chromatogram in the workbench, or load the synthetic example. No account needed.

Open the workbench

Send feedback

What is it about?

At least 5 characters.0 / 4000

So we can reply. Leave it empty to stay anonymous.

Page: /learn/techniques/rpc